Yuan, Xiao-Qing
Chen, Peng
Du, Yin-Xiao
Zhu, Ke-Wei
Zhang, Dao-Yu
Yan, Han
Liu, Han
Liu, Yan-Ling
Cao, Shan
Zhou, Gan
Zeng, Hui
Chen, Shu-Ping
Zhao, Xie-Lan
Yang, Jing
Zeng, Wen-Jing
Chen, Xiao-Ping https://orcid.org/0000-0002-4956-8727
Funding for this research was provided by:
National Natural Science Foundation of China (No.81673518, No.81422052, No.81803638)
National Key R&D Program of China (No.2017YFC0909302)
Clinical Research Foundation of Xiangya Hospital (No.2016L04)
Article History
Received: 28 February 2019
Accepted: 21 June 2019
First Online: 10 July 2019
Ethics approval and consent to participate
: This study was approved by the Ethics Committee of Institute of Clinical Pharmacology, Central South University (Registration Number: CTXY-120025-2) and Chinese Clinical Trial Register (Registration Number: ChiCTR-PPC-14005297). Written informed consent was obtained from all patients or their family members.
: Not applicable.
: The authors declare that they have no competing interests.